Promising new approach to cancer therapy

The research platform Translational Cancer Therapy Research, which was recently established by the Bernhard Keppler and his team have already been working for many years on the development of anti-tumour therapeutics, and have given especial attention to the investigation of metal complexes. Platinum complexes are today among the commonest anti-tumour therapeutics. Roughly every second course of treatment for cancer sufferers contains a platinum complex. Ruthenium and gallium complexes have also become increasingly important in recent years, and to a certain extent are already being used in patient treatment on a trial basis.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)